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would require a few weeks to mature before they might contribute 
to the antidepressant action. However, this conclusion has always 
been debatable since an increase in precursor cell proliferation, 
not in neuronal maturation showed the characteristic delay. From 
a clinical perspective the putative effect latency is now also ques-
tionable because newer studies directly focusing on this issue failed 
to confirm any delayed effectiveness (Posternak and Zimmerman, 
2005; Katz et al., 2006a,b; Mitchell, 2006).
Although, the effect of Flx on the number of proliferating cells in 
the dentate gyrus was first detectable at 14 days in the Malberg study, 
there were already suggestive mean differences at earlier time points. 
We therefore reasoned that there might indeed be acute effects of 
serotonin on adult neurogenesis that were somehow masked by the 
experimental design. A detailed study by Banasr et al. (2004), who had 
detected effects on cell proliferation, pointed into the same direction. 
Originating from our work on differential acute and chronic effects 
of voluntary wheel running on different stages of adult neurogenesis 
(Kronenberg et al., 2003; Steiner et al., 2008), we hypothesized that such 
balanced effect might also exist for serotonin-dependent regulation 
of adult neurogenesis. Our idea was that various serotonin   receptors 
IntroductIon
Serotonin is long known as a potent regulator of adult hippocampal 
neurogenesis (Brezun and Daszuta, 1999, 2000; Radley and Jacobs, 
2002; Santarelli et al., 2003; Banasr et al., 2004), but data on how 
this stimulation is actually achieved are limited and partially con-
tradictory. Given the controversies over the ideas that adult neu-
rogenesis might underlie the pathogenesis of depression and that 
adult neurogenesis might be necessary for antidepressant action 
(Jacobs et al., 2000; D’Sa and Duman, 2002; Sahay and Hen, 2007; 
Kempermann et al., 2008), the potential role of serotonin-based 
antidepressants in the regulation of adult neurogenesis have became 
a matter of broader interest. Malberg et al. (2000) were the first to 
show that cell proliferation and the number of newborn neurons 
derived from the adult subgranular zone (SGZ), the neurogenic 
niche in the adult hippocampal dentate gyrus, is increased after 
prolonged treatment with the selective serotonin reuptake inhibi-
tor (SSRI) fluoxetine (Flx). The neurogenic response had a latency 
of a few weeks. This delay was interpreted as possibly explaining 
the often reported latency in the clinical effect of antidepressants. 
It was postulated that newly generated neurons stimulated by Flx 
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Serotonin (5-HT) appears to play a major role in controlling adult hippocampal neurogenesis and 
thereby it is relevant for theories linking failing adult neurogenesis to the pathogenesis of major 
depression and the mechanisms of action of antidepressants. Serotonergic drugs lacked acute 
effects on adult neurogenesis in many studies, which suggested a surprisingly long latency phase. 
Here we report that the selective serotonin reuptake inhibitor fluoxetine, which has no acute 
effect on precursor cell proliferation, causes the well-described increase in net neurogenesis 
upon prolonged treatment partly by promoting the survival and maturation of new postmitotic 
neurons. We hypothesized that this result is the cumulative effect of several 5-HT-dependent 
events in the course of adult neurogenesis. Thus, we used specific agonists and antagonists 
to 5-HT1a, 2, and 2c receptor subtypes to analyze their impact on different developmental 
stages. We found that 5-HT exerts acute and opposing effects on proliferation and survival or 
differentiation of precursor cells by activating the diverse receptor subtypes on different stages 
within the neuronal lineage in vivo. This was confirmed in vitro by demonstrating that 5-HT1a 
receptors are involved in self-renewal of precursor cells, whereas 5-HT2 receptors effect both 
proliferation and promote neuronal differentiation. We propose that under acute conditions 
5-HT2 effects counteract the positive proliferative effect of 5-HT1a receptor activation. However, 
prolonged 5-HT2c receptor activation fosters an increase in late-stage progenitor cells and early 
postmitotic neurons, leading to a net increase in adult neurogenesis. Our data indicate that 
serotonin does not show effect latency in the adult dentate gyrus. Rather, the delayed response 
to serotonergic drugs with respect to endpoints downstream of the immediate receptor activity 
is largely due to the initially antagonistic and un-balanced action of different 5-HT receptors.
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might have diverse, possibly opposing effects on different stages of 
neuronal development in the adult dentate gyrus leading to different 
net outcomes dependent on the time-point of investigation.
In a very detailed analysis, Encinas et al. have been the first to 
identify the cell types in the course of adult neurogenesis, on which 
serotonin (or the SSRI) acted. Two weeks of treatment with Flx 
increased the number of nestin-GFP-positive, non-radial precursor 
cells in the SGZ (Encinas et al., 2006), type-2a cells in our nomen-
clature (Kempermann et al., 2004). Encinas et al. suggested that the 
increase in type-2a cells was due to increased symmetric divisions as 
opposed to increased asymmetric divisions of the type-1 cells. Here, 
too, chronic treatment with Flx resulted in a net increase in adult 
neurogenesis. The authors suggested a sole effect of serotonin on 
precursor cell proliferation. This interpretation, however partially 
contradicts the diverse effects serotonin has on neuronal develop-
ment in the early embryonic period (Gaspar et al., 2003).
We thus designed the present experiment in order to identify a 
potential mechanism that might help to explain the discrepancies 
between different experimental studies. We used a combination 
of in vivo and cell culture models to study in detail the acute and 
more chronic effects of serotonergic stimulation on the regulation 
of adult neurogenesis.
MaterIals and Methods
anIMals and housIng condItIons
Six to eight weeks old adult female C57Bl/6 mice were purchased 
from Charles River. The second strain we used is a transgenic mouse 
expressing GFP driven by regulation of the nestin gene (Yamaguchi 
et al., 2000). We have previously used this approach to characterize 
nestin-expressing progenitor cells in the dentate gyrus (Kronenberg 
et al., 2003). A third generation of mice expressing enhanced (E) 
GFP under the DCX promoter (Gong et al., 2003) was used to 
investigate the expression of 5-HT receptors on newly born cells 
within their developmental steps (type-2b, type-3 and early imma-
ture postmitotic neurons) in adult hippocampal neurogenesis. The 
BAC transgenic mouse line has been developed within the Gene 
Expression  Nervous  System  Atlas  (GENSAT)  BAC  Transgenic 
Project. Breeding with FVBN mice at the animal facility of the Max 
Delbrück Center, Berlin, generated the transgenic offspring.
Mice were held five per cage under standard laboratory hous-
ing conditions with a light/dark cycle of 12 h each and free access 
to food and water. All experiments were performed according to 
national and institutional guidelines and were approved by an offi-
cial committee (LaGeSo, Berlin, Germany). Fourteen animals per 
experiment were randomly distributed into two groups with the 
same size. One group received the drug, whereas saline was injected 
to the control group.
drug treatMents and experIMental desIgn
For all experiments, animals received a single i.p. injection of bro-
modeoxyuridine (BrdU, 50 mg/kg body weight; Sigma, Deisenhofen, 
Germany) and were killed according to the experimental design in 
Figure 1. A single BrdU injection is adequate and in accordance to 
our earlier studies (Kronenberg et al., 2003; Steiner et al., 2008).
The antidepressant Flx and pharmacological specific agonists 
and  antagonists  were  used  to  dissect  the  interplay  of  various 
serotonin receptor subtypes in regulation of adult hippocampal 
  neurogenesis. All drugs used for pharmacological manipulation of 
receptors were purchased from TOCRIS (Tocris Bioscience, Biozol, 
Germany) and were administered intraperitoneally (i.p.).
The experimental design for the Flx experiment was split into 
three parts (Figure 1). In the first setting we analyzed the number of 
dividing precursor cells at 1 day after one BrdU injection to inves-
tigate an acute effect of the drugs on cell proliferation. The mice 
were first injected with Flx (10 mg/kg body weight in 0.9% saline) or 
0.9% saline vehicle and 24 h later with BrdU. The   animals were then 
Figure 1 | experimental design. (A) Time course of fluoxetine treatment for 
proliferation and survival experiments. Mice were injected either with NaCl 
(Vehicle Control) or fluoxetine once followed by one single injection of BrdU 
24 h later. The survival paradigm is divided into two parts: Mice were injected 
first with BrdU followed by a daily administration of either NaCl or fluoxetine 
over 21 days; a third group received one single injection of fluoxetine followed 
by NaCl (Vehicle) once daily over 20 days. (B) Time course of serotonin 
receptor agonist and antagonist treatments for proliferation and survival 
experiments. Mice were injected once with NaCl (Vehicle Control), the 
antagonist or agonist followed by one single injection of BrdU after 2 h, and 
they were killed 24 h later. For cell survival animals were injected first with 
BrdU followed 8 h later by a daily administration of NaCl, the antagonist or 
agonist over 7 days.Frontiers in Molecular Neuroscience  www.frontiersin.org  July 2010  | Volume 3  | Article 14  |  3
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30–40 min. After washing with PBS, the single cell suspension was 
suspended in a 22 % percoll. This suspension was then centrifuged 
at 1500 rpm for 15 min. The supernatant was discarded and the 
pellet after washing in several rounds of PBS was resuspended in 
media and plated. The surface was coated with Poly-D-lysine 10 μg/
ml and laminin 5 μg/ml.
For self-renewal experiments cells were plated at a very low den-
sity (“clonal density”) of 104 cells/cm2 (Babu et al., 2007). The cells 
were plated in conditioned medium together with fresh medium 
1:1 ratio with 20 ng/ml of both epidermal growth factor (EGF) and 
Fibroblast Growth Factor-2 (FGF-2). The conditioned medium 
was prepared from medium incubated for 48 h in proliferating 
precursor cells.
For differentiating cells were plated at a density of 2 × 104 cells/
cm2.  The  growth  factors  were  withdrawn  the  following  day. 
Wherever  necessary  the  pharmacological  agents  were  added 
while the growth factors were withdrawn. The drugs were added 
to the culture medium in following concentration: 8-OH DPAT 
(2 μM), Ipsapirone (0.1 μM), α-methyl-5-HT-maleate (20 μM), 
WAY161503 (0.5 μM), NAN-190 (3 μM), WAY100135 (2 μM) and 
Cinanserin (30 μM).
For clonal analysis 1000 cells were plated per well of a 96 well 
plate. After 8–10 days spheres were counted and represented as 
percentages.  For  immunocytochemical  analysis,  the  cells  were 
fixed with 4% PFA for 30 min at room temperature. The cells 
were then washed in PBS. The primary and secondary antibod-
ies were incubated in blocking buffers consisting of 5% Donkey 
Serum. Permeabilization was carried out with 0.25% of TritonX-
100, which was only done while blocking and omitted for primary 
antibody incubations.
rt-pcr
Neural  precursor  cells  cultures  were  lysed  in  RLT  buffer  and 
RNA extracted using RNeasy mini kit according to the manu-
facturers  (Invitrogen)  suggestions.  The  RNA  extracted  was 
reverse  transcribed  in  a  50  μl  final  reaction  mix  using  the 
Superscript First-Strand RT reaction kit (Invitrogen) to obtain 
the cDNA. 0.5 μl of the cDNA was used to amplify the gene 
of  interest  with  specific  primers.  The  following  primers  were 
used:  5-HT1aR-Forward-  5′-ATCTCGCTCACTTGGCTCAT 
-3′,  5-HT1aR-Reverse-  5′-  CCACTACCTGGCTGACCATT  -3′, 
5-HT2aRa-Forward-  5′-  ATAGCCGCTTCAACTCCAGA  -3′, 
5-HT2aR-Reverse- 5′- ACGGCCATGATATTGGTGAT-3′, 5-HT2-
cR-Forward- 5′- TGATTGGACTGAGGGACGAAAGCA -3′ and 
5-HT2cR-Reverse- 5′- TTCCCACAAAGCACCGACAGGATA -3′. 
The PCR products were analyzed by agarose gel electrophoresis.
IMMunohIstocheMIstry
Mice  were  deeply  anesthetized  with  ketamine  and  perfused 
transcardially with 0.9% sodium chloride followed by 4% para-
formaldehyde (PFA) in 0.1 M phosphate buffer. Brains were dis-
sected from the skulls, postfixed in 4% PFA at 4°C over night, 
and transferred into 30% sucrose. Brains were cut on a sliding 
microtome (Leica, Bensheim, Germany) in the coronal plane in 
40-μm thick sections and cryoprotected. Sections were stained 
free floating with all antibodies diluted in Tris-buffered saline 
(TBS) containing 3% donkey serum and 0.1% Triton X-100. 
killed after 2 h. The second design focused on the potential effects 
of daily drug administration over 21 days on cell differentiation and 
survival of newly born neurons. Here BrdU was given once before 
the injection of Flx. The third part investigated a lasting effect of 
precursor cell survival after one single injection of Flx followed by 
20 days of 0.9% saline vehicle.
The investigation of the role of serotonin receptor subtypes in 
adult neurogenesis contained two parts per experiment (Figure 1). 
In the first part, the effect on cell proliferation was examined. One 
group of mice was first injected with selective receptor agonists or 
antagonists or 0.9% saline vehicle (see following paragraphs for 
details). One single injection of BrdU followed 2 h later (it takes 
2 h to let the drugs take effect). Mice were killed after 24 h. In the 
second group of animals BrdU was given 8 h (to let the marker 
be incorporated by as many as proliferating cells) before initia-
tion of receptor stimulation or blocking. Cell differentiation and 
survival was discovered by a daily agonist or antagonist injection 
over 7 days.
5-ht1a receptor agonIst and antagonIst
For the in vivo experiment, the standard selective 5-HT1a agonist 
8-OH DPAT (8-hydroxy-2-dipropylaminotetralin hydrobromide) and 
WAY100135 (S-N-tert-Butyl-3-(4-(2-methoxyphenyl))-piperazin-1-
yl)-2-phenylpropanamide dihydrochloride), a potent selective 5-HT1a 
receptor antagonist with partially agonistic affinity, were dissolved 
in 0.9% saline. Dose calculations were based on (Rodgers and Cole, 
1994; Yoshitake and Kehr, 2004). One group of mice received either 
8-OH DPAT (1 mg/kg dissolved in saline, 0.1 ml/20 g) or WAY100135 
(10 mg/kg dissolved in saline, 0.1 ml/20 g), and the control group 
received an equivalent volume of saline. For the in vitro part, another 
5-HT1a receptor antagonist was used, Nan-190 (3 μM), which did not 
worked successfully in vivo. In addition, a second agonist was tested 
in its role on regulation, Ipsapirone (0.1 μM).
5-ht2 and 5-ht2c receptor agonIsts and antagonIsts
Cinanserin hydrochloride (N-(2-((3-(Dimethylamino)propyl)thio)
phenyl)-3-phenyl-2-propenamide hydrochloride) is a widely used 
drug, which blocks the entire 5-HT2 receptor family. One group 
of mice received 2 mg/kg body weight of Cinanserin dissolved in 
saline. Another group of animals was treated with α-methyl-5-
hydroxytryptamine-maleate, which is used as an entire 5-HT2 
receptor family agonist with high affinity in the following con-
centration: 0.5 mg/kg body weight.
The potent and selective 5-HT2c receptor agonist WAY161503 
(8.9-dicloro-2.3.4.4a-tetrahydro-1H-pyrazino(1.2-a)quinoxalin-
5(6H)-one hydrochloride) has partially 5-HT2a agonistic activity 
and is used as an antidepressant following systemic administration 
in vivo. Dose calculations were based on (Welmaker et al., 2000; 
Cryan et al., 2004). One group of mice received 10 mg/kg per body 
weight of WAY161503 dissolved saline; the control group received 
an equivalent volume of saline.
cell culture
Precursor  cells  were  cultured  from  8-  to  12-weeks-old  female 
C57Bl/6 animals. The mice were sacrificed and the dentate gyrus 
dissected out. The tissue from five to six animals was pooled. The 
tissue chunk was digested with papain, Dispase, and DNAse for Frontiers in Molecular Neuroscience  www.frontiersin.org  July 2010  | Volume 3  | Article 14  |  4
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Germany). Appropriate gain and black level settings were deter-
mined on control tissues stained with secondary antibodies 
alone. All images were taken in sequential scanning mode and 
further processed in Adobe Photoshop 7.0 for Macintosh. Only 
general contrast adaptations were made and figures were not 
otherwise manipulated.
To obtain the absolute number of BrdU-labeled cells of a certain 
phenotype we multiplied the absolute number of BrdU-labeled 
cells with the ratio of the phenotype of interest.
statIstIcal analysIs
All numerical analyses were performed using Statview 5.0.1 for 
Macintosh. ANOVA was followed by Fisher’s post hoc test, where 
appropriate. All values are expressed as mean ± SD. p-Values of 
<0.05 were considered statistically significant.
results
FluoxetIne exerts a survIval-proMotIng eFFect on newborn 
cells In the dentate gyrus
Injecting BrdU 24 h before the beginning of 21 days of treatment 
with fluoxetine (Flx, Figure 1) exposed newborn cells to the effect 
of the drug after the completion of their cell cycle. In this para-
digm we found a survival-promoting effect by Flx (Figure 2A). We 
next asked, whether this survival effect might act only on the cells 
that had just undergone division. We thus gave BrdU, injected Flx 
1 day later and continued with daily vehicle saline injections for 
the remainder of the 21-day period. Here no changes were found 
(Figure 2A). This finding points out that acute stimulation by Flx 
does not exert a lasting survival effect.
When  analyzing  the  phenotype  of  BrdU-positive  cells  after 
21 days of prolonged Flx treatment we found that the proportion 
of new neurons (BrdU+/NeuN+) was not influenced by Flx treat-
ment (Figure 2B), resulting in a net increase of newborn neurons 
(Ctr 147 ± 97 vs. Flx 279 ± 110; p = 0.0536; Figure 2C). Interestingly, 
when we looked at the proportion of cells expressing transient 
postmitotic marker Calretinin we found a significant decrease in 
the treatment group (Ctr 49 ± 8.3% vs. Flx 32.6 ± 4.8%; p = 0.0019, 
Figure 2D). No change was found in the number of cells with co-
labeling for BrdU and proliferation marker Ki67 indicating that 
the number of label-retaining proliferating precursor cells was 
not affected.
Since acute treatment with Flx neither affected cell proliferation 
in the adult dentate gyrus (Malberg et al., 2000; Encinas et al., 2006) 
nor cell survival (as shown here), but prolonged treatment with 
Flx showed an effect on neurogenesis, we next studied acute and 
chronic effects driven by different 5-HT receptors.
expressIon oF 5-ht1 and 2 receptors In the adult  
dentate gyrus
We first investigated, whether 5-HT receptors are expressed in 
the adult dentate gyrus and if so, by which cell types. Coronal 
brain sections of adult female mice showed 5-HT1a receptor 
expression in neurons both in the hilus and the granule cell 
layer including the SGZ (Figures 3A,C,D). Our data show that 
the majority of cells in the SGZ do not or only weakly express 
5-HT1a, instead it seems to be a sub-population of cells that 
is positive for the receptor. We hypothesized that among these 
For BrdU staining, DNA was denatured in 2N HCl for 30 min 
at 37°C. Sections were then rinsed in 0.1 M borate buffer and 
washed in TBS.
Primary antibodies were applied in the following concentra-
tions:  anti-BrdU  (rat,  1:500;  Harlan  Seralab,  Indianapolis,  IN, 
USA), anti-GFP (rabbit, 1: 400, Acris Antibodies, DPC Biermann, 
Germany),  anti-GFP  (goat,  1:1000,  Acris  Antibodies,  DPC 
Biermann, Germany), anti-GFP (mouse, 1:400, Acris Antibodies, 
DPC Biermann, Germany), anti-Ki67 (rabbit, 1:500, Novocastra, 
UK), anti-S100β (rabbit, 1:2500; Swant, Belinzona, Switzerland), 
anti-S100β (mouse, 1:1000, SIGMA), anti-NeuN (mouse, 1:100; 
Chemicon, Temecula, CA, USA), anti-DCX (goat, 1:200; Santa 
Cruz Biotechnologies, Santa Cruz, CA, USA) and anti-Calretinin 
(goat, 1:250; Swant, Switzerland) anti-GFAP (guinea pig, 1:1000 
Advanced  ImmunoChemistry),  5-HT1a  Receptor  (guinea  pig, 
1:500, Chemicon), 5-HT2a Receptor (rabbit, 1:250, Sigma), 5-HT2c 
Receptor (rabbit, 1:250, Chemicon).
Immunohistochemistry  followed  the  peroxidase  method 
with  biotinylated  secondary  antibodies  (all:  1:500;  Jackson 
ImmunoResearch Laboratories, West Grove, PA, USA; Distributor 
Dianova,  Hamburg,  Germany),  ABC  Elite  reagent  (Vector 
Laboratories, Burlingame, CA, USA) and diaminobenzidine (DAB; 
Sigma) as chromogen. For immunofluorescence FITC-, RhodX- or 
Cy5-conjugated secondary antibodies were all used at a concen-
tration of 1:250 (Jackson ImmunoResearch). Fluorescent sections 
were coverslipped in polyvinyl alcohol with diazabicyclooctane 
(DABCO, Sigma) as anti-fading agent.
In sItu hybrIdIzatIon
For  in situ hybridization, brains were embedded in Tissue-Tec 
OCT compound (Sakura) and cut in 20-μm thick sections on a 
cryostat. In situ hybridization was performed as follows. DIG-
labeled riboprobe (nucleotide region 1251–1688 of the transcript 
for mouse Htr1a; NCBI reference NM_008308.4) was synthesized 
in vitro with Promega Riboprobe System – SP6/T7, DIG RNA labe-
ling mix (Roche), and purified with RNAeasy mini kit (Qiagen). 
Pre-hybridized cryosections were incubated overnight at 70°C in 
hybridization buffer containing 500 ng/ml of DIG-labeled ribo-
probe. Incubation with alkaline phosphatase-conjugated anti-DIG 
antibody (Roche) followed at 4°C overnight, and staining with 
BCIP/NBT (Sigma-Aldrich) at RT for 1 week. The detection of 
the 5-HT1a receptor transcript was combined with immunofluo-
rescence for BrdU, and DAPI staining to visualize the nuclei. BrdU 
staining was done immediately after in situ hybridization and as 
described above.
QuantIFIcatIon and IMagIng
One-in-six series of sections of each brain were DAB stained, 
and immunoreactive cells were counted throughout the ros-
trocaudal extent of the dentate gyrus. Results were multiplied 
by six to obtain the total number of BrdU-positive cells per 
dentate gyrus. One-in-twelve series of sections were tripled-
labeled as described. For phenotypic analysis of BrdU-labeled 
cells, 100 randomly selected cells per animal were analyzed for 
co-staining with glial or neuronal markers, using a Leica TCS 
SP2 confocal microscope. Confocal microscopy was performed 
using a spectral confocal microscope (TCS SP2; Leica, Bensheim, Frontiers in Molecular Neuroscience  www.frontiersin.org  July 2010  | Volume 3  | Article 14  |  5
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stIMulatIon oF the 5-ht1a receptor Increases cell 
prolIFeratIon In vIvo
In vivo, upon treatment with the selective 5-HT1a receptor ago-
nist 8-OH DPAT BrdU-positive cells formed characteristic clus-
ters in the SGZ of the dentate gyrus (Figures 3I,J) as described 
earlier (Banasr et al., 2004). Acute treatment with 8-OH DPAT 2 h 
pre-BrdU (Figure 1B) significantly increased precursor cell pro-
liferation measured 1 day after BrdU injection (Ctr 1052 ± 106 vs. 
1627 ± 279; p = 0.0062; Figure 4A), whereas 1 week of treatment had 
no significant effect. Analogous treatment with 5-HT1aR antago-
nist WAY100135 showed the opposite pattern with no effect on 
precursor cell proliferation but a significant decrease in the number 
of BrdU-positive cells in animals that received the antagonist for 
7 days (Ctr 670 ± 122 vs. 480 ± 55; p = 0.0019; Figure 4A).
For phenotypic analysis sections were stained with the transient 
neuronal marker Dcx or the neuronal marker NeuN. Calculating 
the net effects on adult neurogenesis thus led to an identical pat-
tern than the BrdU data (Figure 4B): 5-HT1aR agonist (8-OH 
DPAT) treatment increased cell proliferation of Dcx-positive cells 
(Ctr 763 ± 116 vs. 1105 ± 172; p = 0.0119) with the number of 
BrdU-only cells remaining unchanged suggesting a net increase 
the precursor cells of the SGZ would be found. In vitro, hip-
pocampal precursor cells displayed intense 5-HT1a receptor 
expressions (Figure 3B). Confocal images of in situ hybridiza-
tion revealed the typical strong 5-HT1a receptor expression in 
the CA1 region and fainter in the dentate gyrus (Figure 3E). 
Combination of 5-HT1a receptor in situ hybridization with 
BrdU immunohistochemistry further indicated that the recep-
tor is found on proliferating (precursor) cells in the dentate 
gyrus. Strong expression was also found on local interneurons, 
suggesting that some of the observed effects might also be indi-
rect. For further in vivo investigations we used DCX-EGFP 
reporter mice to analyze receptor expression on doublecortin 
(Dcx)-expressing precursor cells in their full morphology. We 
found staining with the 5-HT1a receptor antibody in a few 
Dcx-positive, horizontal type-2 cells in the SGZ (Figure 3D). 
Immunohistochemistry with a selective 5-HT2a receptor anti-
body revealed dense staining in the hilus (Figure 3F) whereas 
staining for 5-HT2c receptors marked the granule cell layer of 
the dentate gyrus (Figure 3G).
In addition RT-PCR of neural precursor cell RNA revealed 
5-HT1a and 5-HT2 receptor expression (Figure 3H).
Figure 2 | effects of acute and chronic fluoxetine treatment. (A) Compared 
to control (Ctr NaCl), chronic but not acute fluoxetine treatment significantly 
increased the number of BrdU-positive cells in the dentate gyrus. Injection of 
BrdU 24 h before the beginning of 21 days chronic fluoxetine administration 
exerted a survival-promoting effect on newborn cells, whereas one single 
injection of the drug followed by 20 days of saline had no effect. Chronic 
fluoxetine treatment resulted in a net increase in newborn cells (C) without 
affecting the proportion of new neurons (BrdU+/NeuN+) (B), but significantly 
decreased the ratio of BrdU-positive cells expressing the transient postmitotic 
marker Calretinin (Cr) (D). Here, the increased proportion of BrdU-labeled  
cells of undetermined phenotype presumably reflects the increase in  
NeuN-positive cells.Frontiers in Molecular Neuroscience  www.frontiersin.org  July 2010  | Volume 3  | Article 14  |  6
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in proliferating type-2b and type-3 cells (see Figure 5) after acute 
5-HT1a receptor stimulation. In contrast, 1 week of treatment 
made this difference disappear and no effect on the total number 
of BrdU/NeuN-positive cells was found. Conversely, the number 
of new neurons significantly decreased after treatment with the 
5-HT1aR antagonist WAY100135 for 7 days (Ctr 572 ± 125 vs. 
404 ± 51; p = 0.0083, Figure 4B).
5-ht2r and 5-ht1ar sIgnalIng have opposItIonal eFFects on 
adult neurogenesIs
Interestingly, in vivo treatment with 5-HT2 receptor antagonist 
Cinanserin resembled the effects of 5-HT1aR agonist. There was 
an acute increase in cell proliferation but no effect after 7 days 
(Figure  4C).  Most  of  the  net  increase  in  BrdU-positive  cells 
was explained by an undetermined phenotype (Ctr 267 ± 115 
vs. 626 ± 245; p = 0.0063) whereas the number of BrdU+/Dcx+ 
cells even decreased (68.5 ± 8.9% vs. 56.1 ± 9.4%; p = 0.0299; 
Figures 4D,E). Staining for GFAP or the endothelial marker Glut1 
revealed no change in GFAP-positive or endothelial cells (data not 
shown). Consequently, the most parsimonious explanation is an 
increase in type-2a progenitor cells, which are Dcx-negative.
For the complementary experiment the 5-HT2 receptor agonist 
α-methyl-5-HT was used. In contrast to the results for the 5-HT1aR 
agonist, we here found a decrease in the number of BrdU-positive 
cells after both 1 and 7 days of treatment (Figure 4C). To further dif-
ferentiate the 5-HT2 receptor driven results the selective 5-HT2cR 
agonist WAY161503 was used. Again, we found a moderate decrease 
in cell proliferation (Ctr 1129 ± 169 vs. 864 ± 161; p = 0.0481; 
Figure 4C), but no effect after 7 days of treatment. Nestin-GFP 
reporter gene mice were used for direct characterization of the 
different types of precursor cells (Yamaguchi et al., 2000; Filippov 
et al., 2003). Phenotypic analysis for acute 5-HT2 receptor agonist 
treatment revealed a net decrease of BrdU/Nestin-GFP-positive 
type-1/2a and BrdU/Nestin-GFP/Dcx-positive type-2b cells with 
type-3 cells and newly postmitotic neurons remaining unchanged 
(Figure 4F). However, 7 days of treatment significantly reduced the 
number of newborn neurons (787 ± 126 vs. 371 ± 145; p = 0.0025; 
Figure 4G). In concert with the data from the antagonist treat-
ment these data confirm that 5-HT2 receptor effects mainly act 
on type-2 precursor cells. Phenotypic analysis for acute 5-HT2cR 
agonist showed a shift from type-1/2a (which decreased) to type-3 
and newly postmitotic cells (which increased), with the type-2b 
stage  being  unaffected  (Figure  4H).  As  with  the  pan-HT5R2 
antagonist, the HT5R2c agonist showed no difference after 7 days 
of treatment.
stIMulatIon oF 5-ht1a receptors In vItro prIMarIly proMotes 
selF-renewal whereas 5-ht2r sIgnalIng Is also Involved In 
neuronal dIFFerentIatIon
To further investigate whether the in vivo effects might occur directly 
on precursor cells, or – as the data on receptor expression might 
suggest – rather indirect by surrounding cells we turned to adher-
ent monolayer cultures (Babu et al., 2007) and three-dimensional 
neurospheres of hippocampal precursor cells.
First, the capacity for self-renewal in the presence of a 5-HT1a 
receptor  antagonist  was  studied  in  a  three-dimensional  neuro-
spheres culture of adult neural precursor cells. Cells were grown at 
Figure 3 | Qualitative results. (A–g) 5-HT1a, 2a and 2c receptor expression 
pattern in vivo, and in vitro. (A) Anti-5-HT1aR staining (DAB reaction) shows 
receptor expression in neurons both in the hilus and granule cell layer 
including the subgranular zone, Scale bar 80 μm. (B) Proliferating precursor 
cells [Nestin, green (B1)] in cell culture show an intense 5-HT1aR expression 
[blue, (B2)], Scale bar 10 μm. (C) 5-HT1a receptor expression in the dentate 
gyrus [Doublecortin, green (C1); 5-HT1aR, red (C2)]. (D) The receptor is 
detectable in horizontal type-2 cells revealed as an overlap with DCX-EGFP 
[green (D1), 5-HT1aR in red (D2). (e) Single focal plane of the hippocampus 
after in situ hybridization with riboprobe for the 5-HT1a receptor, 
immunofluorescence for BrdU, and DAPI; the confocal image reveals strong 
receptor expression in CA1, fainter in the dentate gyrus (DG), and no staining 
in the CA3 region. (F) 5-HT2a receptor expression pattern (red) in the dentate 
gyrus reveals a dense staining in the hilus whereas anti-5-HT2c receptor 
staining [(g), red] mostly marks the granule cell layer (Nestin in green). 
(H) Expression analysis of 5-HT receptors: PCR analysis was done from 
reverse transcribed RNA obtained from neural precursor cells under 
proliferative conditions. There is abundant expression of 5-HT1aR (Lane 1) and 
5-HT2aR (Lane 2). Also low levels of 5-HT2c receptors expressed in the 
precursor cells can be seen (Lane 3). (i,J) Anti-BrdU DAB reaction. A single 
i.p., injection of the 5-HT1aR agonist 8-OH DPAT 2h pre-BrdU increases the 
number of BrdU-positive cells in the subgranular zone (SGZ) 24 h later 
compare to control (CTR in J; GCL, granule cell layer; Scale bar 120 μm).Frontiers in Molecular Neuroscience  www.frontiersin.org  July 2010  | Volume 3  | Article 14  |  7
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Figure 4 | effects of acute and chronic 5-HT1a, 2, and 2c receptor agonists 
and antagonists treatment. (A,B) 5-HT1aR effects. (A) Acute treatment with the 
5-HT1a receptor agonist 8-OH DPAT produces a significant increase in cell 
proliferation 1 day after BrdU injection, whereas chronic stimulation for 1 week has 
no effect. In contrast, acute 5-HT1a receptor blocking with WAY100135 causes no 
change in cell proliferation but decreases the number of BrdU-positive cells 
1 week later. (B) Confocal analysis of the differentiation profile reveals a net 
increase in the proportion of BrdU/DCX-positive cells after acute stimulation, and a 
decrease of newborn neurons (BrdU+/NeuN+) upon chronic treatment with the 
antagonist. (C–H) Effects of acute and chronic 5-HT2 receptor agonist and 
antagonist treatment, and 5-HT2c receptor stimulation on precursor cell 
proliferation and differentiation in the adult dentate gyrus. (C) As compared to 
control, acute treatment with the 5-HT2 receptor antagonist Cinanserin leads to a 
large increase in the number of proliferating cells 1 day after BrdU injection, but 
shows no differences 1 week later. In contrast, acute stimulation with the agonist 
α-methyl-5-HT-maleate as well as chronic treatment over 7 days significantly 
decreases the number of BrdU-positive cells. Acute 5-HT2c receptor agonist 
treatment also decreases cell proliferation, but has no effect on survival. 
Phenotypic analysis reveals a significant decrease in BrdU+/Dcx+ cells after acute 
5-HT2R antagonist treatment (D) that result in a largely net increase in the number 
of BrdU+ cells of undetermined phenotype (e). Phenotypic analysis of acute and 
chronic effects of the 5-HT2R agonist reveal a net decrease in type-1/2a and 
type-2b cells after acute treatment (F), and a significantly reduced number of 
newborn neurons after 7 days (g). Acute 5-HT2c receptor agonist treatment 
exerts a shift from type-1/2a (which decreases) to type-3 and newly postmitotic 
cells (which increases), with the type-2b stage being unaffected (H). Data present 
the absolute number of BrdU-positive cells per dentate gyrus as well as their 
phenotype by percentage and absolute number, mean ± SD. (i) In vitro, 
self-renewal potential of neural precursor cells indicated by the capacity to form 
spheres when plated at clonal densities. Upon 5-HT1aR antagonist (NAN-190) 
addition as well as upon 5-HT2R stimulation with α-methyl-5-HT the self-renewal 
potential was significantly decreased, whereas the 5-HT1aR agonist 8-OH DPAT 
had no effect when added to the culture. (J) Neuronal differentiation of precursor 
cells was detected by β-III-tubulin antibody staining, and the number of neurons 
was counted. 5-HT2R antagonist Cinanserin (Cin) potently decreased neuronal 
differentiation from adult neural precursor cells suggesting an essential role for 
5-HT2R in neuronal differentiation. 5-HT2R agonist addition but not 5-HT2cR 
agonist (WAY161503) also inhibited neuronal differentiation.Frontiers in Molecular Neuroscience  www.frontiersin.org  July 2010  | Volume 3  | Article 14  |  8
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Interestingly, when neural precursor cells were incubated with 
Cinanserin, they did not generate any spheres in the presents of 
the 5-HT2 receptor antagonist. To test whether agonists of 5-HT2 
receptors would play a role in regulating the self-renewal potential 
of hippocampal precursor cells, the 5-HT2R agonist α-methyl-
5-HT was added. Here too, the number of spheres generated was 
significantly decreased as it was for Nan-190 (Ctr 13.18 ± 1.42%, 
α-methyl-5-HT  9.85  ±  0.41%;  p  =  0.002;  Figure 4I).  We  did 
not, however, observe any difference with the selective 5-HT2c 
receptor agonist WAY 161503 (Ctr 13.18 ± 1.42%, WAY 161503 
13.23 ± 0.64%; p = 0.476; Figure 4I). Those in vitro data mirror 
the antagonistic effect of 5-HT1a and 5-HT2 receptors as seen 
in vivo.
Next, the effect on neuronal differentiation of precursor cells 
in vitro was investigated. In the adherent monolayer culture model 
system, differentiation is induced by withdrawal of the growth 
factors. Here, the addition of the selective 5-HT1aR agonist 8-OH 
DPAT failed to regulate neuronal differentiation measured by 
β-III-tubulin expression. Ipsapirone, another 5-HT1a receptor 
agonist revealed the same (not shown). Next, non-stimulant action 
of serotonin via 5-HT1a receptors on neural precursor cells was 
investigated by incubation the cells with 5-HT1a receptor antago-
nists. In this setting the antagonists WAY100135 and NAN-190 
appear to decreased neuronal differentiation but failed to reach 
statistical significance at p = 0.05. These results are in contrast to 
the in vivo data suggesting a rather indirect effect, which will be 
discussed later.
Pharmacological inactivation of 5-HT2 receptors by Cinanserin 
under  differentiation  conditions  instead  showed  a  significant 
reduction in the number of β-III-tubulin-positive neurons (Ctr 
value set to 1, Cinanserin 0.28 ± 0.08; p = 0.0037; Figure 4J). The 
cell density in cultures incubated with Cinanserin reflected the 
effect of the antagonist. Interestingly, we observed a similar but less 
pronounced result upon α-methyl-5-HT incubation, which also 
decreased the fraction of newly generated neurons in presence of 
the 5-HT2 receptor agonist (0.87 ± 0.008; p = 0.0043; Figure 4J). 
We did not detect any statistically significant change in the fraction 
of neurons differentiated upon WAY161503 exposure, the specific 
5HT2c receptor agonist (1.21 ± 0.27; p = 0.5254; Figure 4J).
dIscussIon
The present study shows that in adult mice serotonin influences 
both cell proliferation and the survival of newly generated neu-
rons in the dentate gyrus via different serotonin receptor activities 
(Table 1). We have demonstrated that acute activation of 5-HT1a 
and 5-HT2 receptor subtypes had counteracting effects on cell 
proliferation in vivo and self-renewal in vitro. These observations 
provide insight into why an acute increase in serotonin levels due to 
treatment with Flx does not produce a net increase in cell prolifera-
tion in vivo. The two receptors act antagonistically. Flx indirectly 
activates 5-HT1aR via increasing serotonin levels while a negative 
regulation of neurogenesis through 5-HT2R occurs.
Whereas  acute  activation  increases  proliferation,  prolonged 
inhibition of 5-HT1a receptors results in a decrease in net neuronal 
survival and differentiation. Interestingly, chronic activation of the 
5-HT2 receptor family also produced this effect indicating a lack 
of antagonistic action. Vice versa, blocking the 5-HT2 receptors 
Q4
Figure 5 | Schematic drawing of effects of Flx treatment and 5-HT 
receptors stimulation on adult hippocampal neurogenesis. Under 
baseline levels, from left to right, low proliferative radial glia-like cells (type-1 
with GFAP-expression) give rise to three stages of transient amplifying 
lineage-determined progenitor cells (type-2a, -2b, and 3 with Dcx-expression) 
to postmitotic immature granule cells (transient Calretinin-expression) and 
mature neurons. The middle panel highlighted in color, shows the effect of 
acute and chronically manipulated serotonin levels on proliferation and 
differentiation. While 5-HT receptors reveal a balanced net effect on earlier 
stages, the SSRI Flx effect more advanced stages and increases net 
neurogenesis. The bottom panel in comparison summarizes the data by 
Encinas et al. (2006), who proposed a selective effect on early precursor cell 
proliferation and increased net neurogenesis.
low density in the presence of the mitogens EGF and FGF-2 to allow 
self-renewal when the 5-HT1a receptor antagonist NAN-190 was 
added. NAN-190 significantly decreased the percentage of secondary 
spheres generated by the individualized cells (Ctr 18.56 ± 0.75, NAN 
14.92 ± 1.22; p = 0.0349, Figure 4I). Treatment with the selective 
5-HT1a receptor agonist 8-OH DPAT did not significantly affect the 
sphere forming capacity of neural precursor cells (Figure 4I).Frontiers in Molecular Neuroscience  www.frontiersin.org  July 2010  | Volume 3  | Article 14  |  9
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in accordance with our results (Cinanserin in Figure 4C). Both 
studies achieve the impact of serotonin receptor subtype 2c in 
antidepressant action.
Our results of 5-HT2 receptor stimulation in vivo differ from 
an earlier study (Banasr et al., 2004), which can be explained by 
differences in the experimental design and the drugs used (Table 2). 
Banasr et al. (2004) have shown that acute treatment with either 
DOI, a 5-HT2 receptor family agonist, or the selective 5-HT2c 
receptor agonist RO 600175 have no effect on cell proliferation in 
the SGZ of the dorsal hippocampus (2 h after BrdU). Our paradigm 
(24 h after BrdU) catches a larger number of proliferating cells (and 
throughout the SGZ of the entire dorsal and ventral hippocampus) 
and reflects the pool of proliferating and label-retaining progenitor 
cells. As depicted in Figures 4C,H, our protocol with 5-HT2c ago-
nist treatment decreases the number of BrdU+ cells after 24 h but 
increases the relative number of “late” type-3 progenitor cells over 
7 days. Taken together these results suggest that 5-HT2c receptor 
activity promotes proliferation and differentiation of neuronally 
determined progenitor cells.
Furthermore, the present study demonstrates that serotonin 
receptor modulation is seen on sequential steps in the course of 
adult neurogenesis (Figure 5). To distinguish precursor cell stages, 
Nestin-GFP/GFAP-co-expression was used to mark type-1, whereas 
Nestin alone as type-2a and Nestin/Dcx-expression constituting 
type-2b. Type-3 cells characterize immature neurons with tran-
sient Dcx-expression, whereas early postmitotic immature granule 
cells also express Calretinin and NeuN (Kempermann et al., 2004). 
The acute stimulating effect through 5-HT1a receptors affected 
Dcx-positive cells, i.e., from type-2b onward, whereas activation of 
5-HT2 also strongly affected Dcx-negative cells, most likely type-2a 
cells. As development proceeds from type-2a to type-2b and -3, the 
decrease in proliferation in response to 5-HT2 receptor activation is 
offset by the increase in proliferation at a later stage due to 5-HT1a 
receptor activation. The present data in vivo and vitro show that 
the phase of neuronal survival is influenced by 5-HT1a receptors 
while the phase of neuronal differentiation during transient Dcx-
expression is regulated by 5-HT2 receptors. One problem with this 
hypothesis is that the key cell population of interest, the type-3 
cells, is comparatively small, so that a large number of Nestin-GFP 
reporter gene mice would be needed to obtain the necessary power. 
In a study on the effect of kainic acid-induced seizures on adult 
neurogenesis we were able to detect a type-3-cell specific effect, 
but the seizure stimulus is much stronger than the pro-neurogenic 
effect of serotonin (Jessberger et al., 2005).
did not cause a decrease in net neurogenesis that would mirror the 
down-regulatory effect of the 5-HT1a receptor antagonists. This 
might suggest that 5-HT1a activation is more required for baseline 
regulation of net neurogenesis, whereas 5-HT2 receptor activa-
tion is not. Consequently, adult neurogenesis might be functionally 
more sensitive to 5-HT1a receptor-mediated effects than to 5-HT2. 
This interpretation is supported by reports showing that 5-HT1a 
receptors are required for Flx-induced hippocampal neurogenesis 
(Santarelli et al., 2003) but does not explain the latency as observed 
by Malberg et al. (2000).
Yet, others proposed that 5-HT1a agonists also stimulate presy-
naptic receptors in the raphe nuclei, which inhibit the firing rate of 
serotonergic neurons and consequently reduce the signal at target 
postsynaptic receptors in the hippocampus. The time serotonergic 
raphe neurons need to regain their normal firing rate (increased 
activation) would explain the delay of therapeutic action (Blier, 
2003). The apparent clinical effect latency of SSRIs has been ques-
tioned by several studies (Posternak and Zimmerman, 2005; Katz 
et al., 2006a,b, Mitchell, 2006). With respect to the link between 
this delay and the dynamics of adult neurogenesis we here add 
another argument.
Prolonged 5-HT2c receptor activation fostered an increase 
in late-stage progenitor cells and early postmitotic neurons, 
leading to a net increase in adult neurogenesis, similar to the 
effect of chronic Flx treatment. We propose that the balance 
between the two receptors that is seen under acute stimula-
tion in vivo is lost after prolonged stimulation, because the 
5-HT1a receptor-mediated effects will generate more cells that 
are responsive to the 5-HT2 receptor-mediated effects, thereby 
increasing both the number of proliferating late-stage precursor 
cells and net adult neurogenesis (Figure 5). A recently pub-
lished study by Soumier et al. (2009a,b) also reported a 5-HT2c 
receptor-mediated effect in adult neurogenesis and antidepres-
sant treatment (Soumier et al., 2009a). The authors have shown 
that the selective 5-HT2cR antagonist SB243213 increased cell 
proliferation but not survival in the ventral hippocampus and 
thus partially mimicked the effect of the novel antidepressant 
agomelatine (Soumier et al., 2009b). The antagonist effect is 
Table 2 | Comparison of different 5-HT receptor studies.
  Banasr et al. (2004)  Our study
Animals  Rats  Mice
BrdU i.p.  75 mg/kg body weight  50 mg/kg body weight
Treatment paradigm   
5-HT2 receptor family  No effect with DOI (agonist)  ↓ α-methyl-5-HT 
    (agonist)
5-HT2c receptor  No effect with RO 600175  ↓ WAY161503 
  (selective agonist)  (selective agonist)
Table 1 | Acute vs. chronic effects of fluoxetine and various serotonin 
receptor agonist and antagonist on adult hippocampal 
neurogenesis in vivo.
  Proliferation  Survival
    21 days after BrdU
SSRI fluoxetine  –  ↑
    7 days after BrdU
5-HT1aR
8-OH DPAT (selective agonist)  ↑ –
WAY100135 (antagonist)  –  ↓
5-HT2R (entire family)
α-methyl-5-HT (agonist)  ↓  ↓
Cinanserin (antagonist)  ↑ –
5-HT2cR
WAY161503 (selective agonist)  ↓ –Frontiers in Molecular Neuroscience  www.frontiersin.org  July 2010  | Volume 3  | Article 14  |  10
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In line with other studies our data specify that chronic Flx 
treatment increased survival and differentiation of newborn 
cells (Encinas et al., 2006; Wang et al., 2008). In contrast to the 
Malberg study, however, Flx treatment in our hands had no 
effect on cell proliferation (Malberg et al., 2000). Table 3 shows 
a summary of the different treatment paradigms. It remains 
to be shown whether and how chronic Flx treatment might 
change the relative composition of the precursor cell pool in 
the course of adult neurogenesis. We have seen that 21 days of 
prolonged Flx treatment decreases the number of cells at the 
Calretinin stage despite an increase in net neurogenesis (NeuN 
co-expression). We interpret this as increased maturation of 
the newborn neurons, presumably shortening the Calretinin-
positive stage and thereby lowering the number of cells at this 
stage at a given time. Chronic Flx treatment might promote and 
accelerate neuronal differentiation. These data are in line with a 
recent report suggesting that chronic Flx administration led to 
an increase in neuronal maturation (Wang et al., 2008) which 
would here be reflected in a decrease of cells at the Calretinin-
positive immature neuronal stage.
To complete the picture of serotonin action on regulation of 
adult hippocampal neurogenesis and thus to get insights of anti-
depressant action, it is important to know to which degree the 
observed effects are direct or indirect. As depicted in Figure 3, 
our data on receptor expressions suggest a rather indirect effect 
by surrounding cells. There are 5-HT receptors on precursor cells 
of the SGZ but expression on local interneurons is actually more 
prominent. For a detailed analysis, we have tested the effect of the 
5-HT2c receptor subtype on adult neurogenesis due to its earlier 
Table 3 | Comparison of studies on Fluoxetine and adult neurogenesis.
  Malberg et al. (2000)  encinas et al. (2006)  Our study
Species  Rat  Mouse  Mouse
Fluoxetine  1× per day for 1, 5, 14, or 28 days;   1× per day for 15 days; 10 mg/kg  1× per day for 1 or 21 days; 10 mg/kg 
  5 mg/kg body weight  body weight  body weight
BrdU  Day 4 after treatment  Day 14 of treatment  Day 1 before treatment
End of experiment  2 h, 24 h, or 28 days after BrdU  24 h or 30 days after BrdU  22 days after BrdUFrontiers in Molecular Neuroscience  www.frontiersin.org  July 2010  | Volume 3  | Article 14  |  11
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